-
1
-
-
34250020201
-
Hepatocellular carcinoma: Epidemiology and molecular carcinogenesis
-
El-Serag HB, Rudolph KL. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 2007; 132: 2557-2576.
-
(2007)
Gastroenterology
, vol.132
, pp. 2557-2576
-
-
El-Serag, H.B.1
Rudolph, K.L.2
-
2
-
-
63049133092
-
Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005
-
Altekruse SF, McGlynn KA, Reichman ME. Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005. J Clin Oncol 2009; 27: 1485-1491.
-
(2009)
J Clin Oncol
, vol.27
, pp. 1485-1491
-
-
Altekruse, S.F.1
McGlynn, K.A.2
Reichman, M.E.3
-
3
-
-
84873902214
-
Current concepts in hepatic resection for hepatocellular carcinoma in cirrhotic patients
-
Cucchetti A, Cescon M, Trevisani F, et al. Current concepts in hepatic resection for hepatocellular carcinoma in cirrhotic patients. World J Gastroenterol 2012; 18: 6398-6408.
-
(2012)
World J Gastroenterol
, vol.18
, pp. 6398-6408
-
-
Cucchetti, A.1
Cescon, M.2
Trevisani, F.3
-
4
-
-
0036189111
-
Prognostic prediction and treatment strategy in hepatocellular carcinoma
-
Jordi B, Josep ML. Prognostic prediction and treatment strategy in hepatocellular carcinoma. Hepatology 2002; 35: 519-524.
-
(2002)
Hepatology
, vol.35
, pp. 519-524
-
-
Jordi, B.1
Josep, M.L.2
-
5
-
-
0036096420
-
Hepatocellular carcinoma: Diagnosis and treatment
-
Befeler AS, Di Bisceglie AM. Hepatocellular carcinoma: diagnosis and treatment. Gastroenterology 2002; 122: 1609-1619.
-
(2002)
Gastroenterology
, vol.122
, pp. 1609-1619
-
-
Befeler, A.S.1
Di Bisceglie, A.M.2
-
6
-
-
0027458323
-
Risk factors for tumor recurrence and prognosis after curative resection of hepatocellular carcinoma
-
Ikeda E, Saitoh S, Tsubota A, et al. Risk factors for tumor recurrence and prognosis after curative resection of hepatocellular carcinoma. Cancer 1993; 71: 19-25.
-
(1993)
Cancer
, vol.71
, pp. 19-25
-
-
Ikeda, E.1
Saitoh, S.2
Tsubota, A.3
-
7
-
-
79751492851
-
NF-κB in the liver - linking injury, fibrosis and hepatocellular carcinoma
-
Luedde T, Schwabe RF. NF-κ B in the liver - linking injury, fibrosis and hepatocellular carcinoma. Nat Rev Gastroenterol Hepatol 2011; 8: 108-118.
-
(2011)
Nat Rev Gastroenterol Hepatol
, vol.8
, pp. 108-118
-
-
Luedde, T.1
Schwabe, R.F.2
-
8
-
-
4644324186
-
NF-κB functions as a tumour promoter in inflammation-associated cancer
-
Pikarsky E, Porat RM, Stein I, et al. NF-κ B functions as a tumour promoter in inflammation-associated cancer. Nature 2004; 431: 461-466.
-
(2004)
Nature
, vol.431
, pp. 461-466
-
-
Pikarsky, E.1
Porat, R.M.2
Stein, I.3
-
9
-
-
0035139792
-
Therapeutic potential of inhibition of the NF-κB pathway in the treatment of inflammation and cancer
-
Yamamoto Y, Gaynor RB. Therapeutic potential of inhibition of the NF-κ B pathway in the treatment of inflammation and cancer. J Clin Invest 2001; 107: 135-142.
-
(2001)
J Clin Invest
, vol.107
, pp. 135-142
-
-
Yamamoto, Y.1
Gaynor, R.B.2
-
10
-
-
12144289400
-
Aphysical and functional map of the human TNFα/NF-κ B signal transduction pathway
-
Bouwmeester T, BauchA, Ruffner H, et al. Aphysical and functional map of the human TNFα/NF-κ B signal transduction pathway. Nat Cell Biol 2004; 6: 97-105.
-
(2004)
Nat Cell Biol
, vol.6
, pp. 97-105
-
-
Bouwmeester, T.1
Bauch, A.2
Ruffner, H.3
-
11
-
-
0037044575
-
The Iκ B- NF-κ B signaling module: Temporal control and selective gene activation
-
Hoffmann A, Levchenko A, Scott ML, et al. The Iκ B- NF-κ B signaling module: temporal control and selective gene activation. Science 2002; 298: 1241-1245.
-
(2002)
Science
, vol.298
, pp. 1241-1245
-
-
Hoffmann, A.1
Levchenko, A.2
Scott, M.L.3
-
12
-
-
54049155149
-
C-IAP1 and c-IAP2 are critical mediators of tumor necrosis factor-α (TNFα)-induced NF-κB activation
-
Varfolomeev E, Goncharov T, Fedorova AV, et al. c-IAP1 and c-IAP2 are critical mediators of tumor necrosis factor-α (TNFα)-induced NF-κ B activation. J Biol Chem 2008; 283: 24295-24299.
-
(2008)
J Biol Chem
, vol.283
, pp. 24295-24299
-
-
Varfolomeev, E.1
Goncharov, T.2
Fedorova, A.V.3
-
13
-
-
85047692516
-
Aggarwal. Signalling pathways of the TNF superfamily: A double-edged sword
-
Bharat B. Aggarwal. Signalling pathways of the TNF superfamily: a double-edged sword. Nat Rev Immunol 2003; 3: 745-756.
-
(2003)
Nat Rev Immunol
, vol.3
, pp. 745-756
-
-
Bharat, B.1
-
14
-
-
47749089820
-
Regulation of TNFR1 and CD95 signalling by receptor compartmentalization
-
Schütze S, Tchikov V, Wulf SB. Regulation of TNFR1 and CD95 signalling by receptor compartmentalization. Nat Rev Mol Cell Biol 2008; 9: 655-662.
-
(2008)
Nat Rev Mol Cell Biol
, vol.9
, pp. 655-662
-
-
Schütze, S.1
Tchikov, V.2
Wulf, S.B.3
-
15
-
-
0025266685
-
Activation in vitro of NF-κ B by phosphorylation of its inhibitor IκB
-
Ghosh S, Baltimore D. Activation in vitro of NF-κ B by phosphorylation of its inhibitor Iκ B. Nature 1990; 344: 678-682.
-
(1990)
Nature
, vol.344
, pp. 678-682
-
-
Ghosh, S.1
Baltimore, D.2
-
16
-
-
39949085247
-
IKKã (NEMO) is involved in the coordination of the AP-1 and NF-κ B pathways
-
Shifera AS, Friedman JM, Horwitz MS. IKKã (NEMO) is involved in the coordination of the AP-1 and NF-κ B pathways. Mol Cell Biochem 2008; 310: 181-190.
-
(2008)
Mol Cell Biochem
, vol.310
, pp. 181-190
-
-
Shifera, A.S.1
Friedman, J.M.2
Horwitz, M.S.3
-
17
-
-
0037593903
-
Tumor necrosis factor receptor-associated death domain protein is involved in the neurotrophin receptor-mediated anti-apoptotic activity of nerve growth factor in breast cancer cells
-
El YI, Adriaenssens E, Dolle L, et al. Tumor necrosis factor receptor-associated death domain protein is involved in the neurotrophin receptor-mediated anti-apoptotic activity of nerve growth factor in breast cancer cells. J Biol Chem 2003; 278: 16952-16956.
-
(2003)
J Biol Chem
, vol.278
, pp. 16952-16956
-
-
El, Y.I.1
Adriaenssens, E.2
Dolle, L.3
-
18
-
-
0033636538
-
Solution structure of N-TRADD and characterization of the interaction of N-TRADD and C-TRAF2, a key step in the TNFR1 signaling pathway
-
Tsao DH, McDonagh T, Telliez JB, et al. Solution structure of N-TRADD and characterization of the interaction of N-TRADD and C-TRAF2, a key step in the TNFR1 signaling pathway. Mol Cell 2000; 5: 1051-1057.
-
(2000)
Mol Cell
, vol.5
, pp. 1051-1057
-
-
Tsao, D.H.1
McDonagh, T.2
Telliez, J.B.3
-
19
-
-
84859072803
-
Signal transduction by tumor necrosis factor receptors
-
Cabal-Hierro L, Lazo PS. Signal transduction by tumor necrosis factor receptors. Cell Signal 2012; 24: 1297-1305.
-
(2012)
Cell Signal
, vol.24
, pp. 1297-1305
-
-
Cabal-Hierro, L.1
Lazo, P.S.2
-
20
-
-
33646034316
-
Activation of IKK by TNFα requires site-specific ubiquitination of RIP1 and polyubiquitin binding by NEMO
-
Ea CK, Deng L, Xia ZP, et al. Activation of IKK by TNFα requires site-specific ubiquitination of RIP1 and polyubiquitin binding by NEMO. Mol Cell 2006; 22: 245-257.
-
(2006)
Mol Cell
, vol.22
, pp. 245-257
-
-
Ea, C.K.1
Deng, L.2
Xia, Z.P.3
-
21
-
-
77953923379
-
Sphingosine-1-phosphate is amissing cofactor for the E3 ubiquitin ligase TRAF2
-
Alvarez SE, Harikumar KB,Hait NC, et al. Sphingosine-1-phosphate is amissing cofactor for the E3 ubiquitin ligase TRAF2. Nature 2010; 465: 1084-1088.
-
(2010)
Nature
, vol.465
, pp. 1084-1088
-
-
Alvarez, S.E.1
Harikumar, K.B.2
Hait, N.C.3
-
22
-
-
67649500009
-
GOLPH3 modulates mTOR signalling and rapamycin sensitivity in cancer
-
Scott KL, Kabbarah O, LiangMC, et al. GOLPH3 modulates mTOR signalling and rapamycin sensitivity in cancer. Nature 2009; 459: 1085-1090.
-
(2009)
Nature
, vol.459
, pp. 1085-1090
-
-
Scott, K.L.1
Kabbarah, O.2
Liang, M.C.3
-
23
-
-
84864452759
-
Overexpression of GOLPH3 promotes proliferation and tumorigenicity in breast cancer via suppression of the FOXO1 transcription factor
-
Zeng ZL, Lin H, Zhao XH, et al. Overexpression of GOLPH3 promotes proliferation and tumorigenicity in breast cancer via suppression of the FOXO1 transcription factor. Clin Cancer Res 2012; 18: 4059-4069.
-
(2012)
Clin Cancer Res
, vol.18
, pp. 4059-4069
-
-
Zeng, Z.L.1
Lin, H.2
Zhao, X.H.3
-
24
-
-
84865053189
-
GOLPH3 overexpression correlates with tumor progression and poor prognosis in patients with clinically N0 oral tongue cancer
-
Li H, Guo L, Chen SW, et al. GOLPH3 overexpression correlates with tumor progression and poor prognosis in patients with clinically N0 oral tongue cancer. J Transl Med 2012; 10: 168.
-
(2012)
J Transl Med
, vol.10
, pp. 168
-
-
Li, H.1
Guo, L.2
Chen, S.W.3
-
25
-
-
84866512281
-
Increased expression of Golgi phosphoprotein-3 is associated with tumor aggressiveness and poor prognosis of prostate cancer
-
Hua X, Yu L, Pan W, et al. Increased expression of Golgi phosphoprotein-3 is associated with tumor aggressiveness and poor prognosis of prostate cancer. Diagn Pathol 2012; 7: 127.
-
(2012)
Diagn Pathol
, vol.7
, pp. 127
-
-
Hua, X.1
Yu, L.2
Pan, W.3
-
26
-
-
79953166050
-
Isolation of primary human hepatocytes from normal and diseased liver tissue: A one hundred liver experience
-
Bhogal RH, Hodson J, Bartlett DC, et al. Isolation of primary human hepatocytes from normal and diseased liver tissue: a one hundred liver experience. PLoS One 2011; 6: e18222.
-
(2011)
PLoS One
, vol.6
, pp. e18222
-
-
Bhogal, R.H.1
Hodson, J.2
Bartlett, D.C.3
-
27
-
-
0035913278
-
TAK1 is a ubiquitin-dependent kinase of MKK and IKK
-
Wang C, Deng L, Hong M, et al. TAK1 is a ubiquitin-dependent kinase of MKK and IKK. Nature 2001; 412: 346-351.
-
(2001)
Nature
, vol.412
, pp. 346-351
-
-
Wang, C.1
Deng, L.2
Hong, M.3
-
28
-
-
0034568260
-
GMx33: A novel family of trans-Golgi proteins identified by proteomics
-
Wu CC, Taylor RS, Lane DR, et al. GMx33: a novel family of trans-Golgi proteins identified by proteomics. Traffic 2000; 1: 963-975.
-
(2000)
Traffic
, vol.1
, pp. 963-975
-
-
Wu, C.C.1
Taylor, R.S.2
Lane, D.R.3
-
29
-
-
70349835304
-
GOLPH3 bridges phosphatidylinositol-4-phosphate and actomyosin to stretch and shape the Golgi to promote budding
-
Dippold HC, Ng MM, Farber-Katz SE, et al. GOLPH3 bridges phosphatidylinositol-4-phosphate and actomyosin to stretch and shape the Golgi to promote budding. Cell 2009; 139: 337-351.
-
(2009)
Cell
, vol.139
, pp. 337-351
-
-
Dippold, H.C.1
Ng, M.M.2
Farber-Katz, S.E.3
-
30
-
-
84920723013
-
An oncogenic protein Golgi phosphoprotein 3 up-regulates cell migration via sialylation
-
Isaji T, Im S, Gu W, et al. An oncogenic protein Golgi phosphoprotein 3 up-regulates cell migration via sialylation. J Biol Chem 2014; 17: 229-237.
-
(2014)
J Biol Chem
, vol.17
, pp. 229-237
-
-
Isaji, T.1
Im, S.2
Gu, W.3
-
31
-
-
84866512281
-
Increased expression of Golgi phosphoprotein-3 is associated with tumor aggressiveness and poor prognosis of prostate cancer
-
Hua X, Yu L, Pan W, et al. Increased expression of Golgi phosphoprotein-3 is associated with tumor aggressiveness and poor prognosis of prostate cancer. Diagn Pathol 2012; 7: 127.
-
(2012)
Diagn Pathol
, vol.7
, pp. 127
-
-
Hua, X.1
Yu, L.2
Pan, W.3
-
32
-
-
84919845478
-
High expression of Golgi phosphoprotein-3 is associated with poor survival in patients with hepatocellular carcinoma
-
Hu GS, Li YQ, Yang YM, et al. High expression of Golgi phosphoprotein-3 is associated with poor survival in patients with hepatocellular carcinoma. Tumour Biol 2014; 35: 8625-8632.
-
(2014)
Tumour Biol
, vol.35
, pp. 8625-8632
-
-
Hu, G.S.1
Li, Y.Q.2
Yang, Y.M.3
-
33
-
-
84906066890
-
GOLP3 is a predictor of survival in patients with hepatocellular carcinoma
-
JianXin J, Cha Y, ZhiPeng L, et al. GOLP3 is a predictor of survival in patients with hepatocellular carcinoma. Clin Invest Med 2014; 37: E233.
-
(2014)
Clin Invest Med
, vol.37
, pp. E233
-
-
JianXin, J.1
Cha, Y.2
ZhiPeng, L.3
-
34
-
-
0033020416
-
Role of α-fetoprotein in the diagnosis and management of hepatocellular carcinoma
-
Philip J. Role of α-fetoprotein in the diagnosis and management of hepatocellular carcinoma. J Gastroenterol Hepatol 1999; 14: 32-36.
-
(1999)
J Gastroenterol Hepatol
, vol.14
, pp. 32-36
-
-
Philip, J.1
-
35
-
-
33947204625
-
Gene expression profiling reveals potential biomarkers of human hepatocellular carcinoma
-
Jia HL, Ye QH, Qin LX, et al. Gene expression profiling reveals potential biomarkers of human hepatocellular carcinoma. Clin Cancer Res 2007; 13: 1133-1139.
-
(2007)
Clin Cancer Res
, vol.13
, pp. 1133-1139
-
-
Jia, H.L.1
Ye, Q.H.2
Qin, L.X.3
-
36
-
-
84880592164
-
New progress of non-surgical treatments for hepatocellular carcinoma
-
Cheng JW, Lv Y. New progress of non-surgical treatments for hepatocellular carcinoma. Med Oncol 2013; 30: 381.
-
(2013)
Med Oncol
, vol.30
, pp. 381
-
-
Cheng, J.W.1
Lv, Y.2
-
37
-
-
0023200184
-
A random phase II study of mitoxantrone and cisplatin in patients with hepatocellular carcinoma. An ECOG study
-
Falkson G, Ryan LM, Johnson LA, et al. A random phase II study of mitoxantrone and cisplatin in patients with hepatocellular carcinoma. An ECOG study. Cancer 1987; 60: 2141-2145.
-
(1987)
Cancer
, vol.60
, pp. 2141-2145
-
-
Falkson, G.1
Ryan, L.M.2
Johnson, L.A.3
-
38
-
-
0028862265
-
Epirubicin, cisplatin and infusional 5-fluorouracil (5-FU) (ECF) in hepatobiliary tumours
-
Ellis PA, Norman A, Hill A, et al. Epirubicin, cisplatin and infusional 5-fluorouracil (5-FU) (ECF) in hepatobiliary tumours. Eur J Cancer 1995, 31A: 1594-1598.
-
(1995)
Eur J Cancer
, vol.31 A
, pp. 1594-1598
-
-
Ellis, P.A.1
Norman, A.2
Hill, A.3
-
39
-
-
70349171689
-
The current practice of transarterial chemoembolization for the treatment of hepatocellular carcinoma
-
Sung WS. The current practice of transarterial chemoembolization for the treatment of hepatocellular carcinoma. Korean J Radiol 2009; 10: 425-434.
-
(2009)
Korean J Radiol
, vol.10
, pp. 425-434
-
-
Sung, W.S.1
-
40
-
-
33749261599
-
Angiogenesis and antiangiogenic therapy in hepatocellular carcinoma
-
Pang R, Poon RT. Angiogenesis and antiangiogenic therapy in hepatocellular carcinoma. Cancer Lett 2006; 242: 151-167.
-
(2006)
Cancer Lett
, vol.242
, pp. 151-167
-
-
Pang, R.1
Poon, R.T.2
-
41
-
-
47949116252
-
Sorafenib in advanced hepatocellular carcinoma
-
Llovet JM, Ricci S, Mazzaferro V, et al. Sorafenib in advanced hepatocellular carcinoma. N Engl J Med 2008; 359: 378-390.
-
(2008)
N Engl J Med
, vol.359
, pp. 378-390
-
-
Llovet, J.M.1
Ricci, S.2
Mazzaferro, V.3
-
42
-
-
44849117768
-
Akt-dependent regulation of NF-κ B is controlled by mTOR and Raptor in associationwith IKK
-
Dan HC, Cooper MJ, Cogswell PC, et al. Akt-dependent regulation of NF-κ B is controlled by mTOR and Raptor in associationwith IKK. Genes Dev 2008; 22: 1490-1500.
-
(2008)
Genes Dev
, vol.22
, pp. 1490-1500
-
-
Dan, H.C.1
Cooper, M.J.2
Cogswell, P.C.3
-
43
-
-
0037379425
-
Hepatitis C virus RNA replication occurs on a detergent-resistant membrane that cofractionates with caveolin-2
-
Shi ST, Lee KJ, Aizaki H, et al. Hepatitis C virus RNA replication occurs on a detergent-resistant membrane that cofractionates with caveolin-2. J Virol 2003; 77: 4160-4168.
-
(2003)
J Virol
, vol.77
, pp. 4160-4168
-
-
Shi, S.T.1
Lee, K.J.2
Aizaki, H.3
-
44
-
-
79952322370
-
Inhibitors of endoplasmic reticulum α-glucosidases potently suppress hepatitis C virus virion assembly and release
-
Qu X, Pan X, Weidner J, et al. Inhibitors of endoplasmic reticulum α-glucosidases potently suppress hepatitis C virus virion assembly and release. Antimicrob Agents Chemother 2011; 55: 1036-1044.
-
(2011)
Antimicrob Agents Chemother
, vol.55
, pp. 1036-1044
-
-
Qu, X.1
Pan, X.2
Weidner, J.3
-
45
-
-
84865037783
-
Role of phosphatidylinositol 4-phosphate (PI4P) and its binding protein GOLPH3 in hepatitis C virus secretion
-
Bishé B, Syed GH, Field SJ, et al. Role of phosphatidylinositol 4-phosphate (PI4P) and its binding protein GOLPH3 in hepatitis C virus secretion. J Biol Chem 2012; 287: 27637-27647.
-
(2012)
J Biol Chem
, vol.287
, pp. 27637-27647
-
-
Bishé, B.1
Syed, G.H.2
Field, S.J.3
-
46
-
-
33750466230
-
Introduction to NF-κ B: Players, pathways, perspectives
-
Gilmore TD. Introduction to NF-κ B: players, pathways, perspectives. Oncogene 2006; 25(51): 6680-6684.
-
(2006)
Oncogene
, vol.25
, Issue.51
, pp. 6680-6684
-
-
Gilmore, T.D.1
-
47
-
-
0033595892
-
The Rel/NF-κ B signal transduction pathway: Introduction
-
Gilmore TD. The Rel/NF-κ B signal transduction pathway: introduction. Oncogene 1999; 18: 6842-6844.
-
(1999)
Oncogene
, vol.18
, pp. 6842-6844
-
-
Gilmore, T.D.1
|